Back to results
US 2026/0069665 A1Published application
Systems and methods for epicardial tissue distension solutions
AssigneeEdwards Lifesciences Corporation
InventorMazen Saadi Albaghdadi
Life of this patent
Estimating the term…
Abstract
Systems and methods for improving epicardial tissue distension are described. Drug delivery elements can deliver drugs that can dissolve epicardial fat and/or weaken pericardial connective tissue. Distension systems can provide mechanical distension of the pericardium. The drug delivery and the distension systems can be combined to improve epicardial tissue distension.
Claims20
A system for improving epicardial tissue distension, comprising:
- a plurality of drug delivery elements configured for attachment to epicardial tissue of a heart;
- wherein the plurality of drug delivery elements comprises a lipolysis drug for breaking down epicardial fat.
A system for improving heart function by enhancing epicardial tissue distension, the
- system comprising:
- an elongate catheter;
- and
- a drug delivery element coupled to a distal end portion of the elongate catheter, wherein the drug delivery element includes an anchoring feature for attachment along a surface of epicardial tissue of a heart;
- wherein the drug delivery element releases a lipolysis drug after attachment to the epicardial tissue.
2 more elements
A system for mitigating complications related to heart failure by allowing enhanced
- epicardial tissue distension, the system comprising:
- an elongate catheter;
- a drug delivery element coupled to a distal end portion of the elongate catheter, wherein the drug delivery element includes an anchoring feature for attachment to a surface of epicardial tissue in a heart, wherein the drug delivery element controllably releases a lipolysis drug into the heart for dissolving epicardial fat;
- and
- a pushing mechanism shaped for deployment in an epicardial space for providing an outward force on a pericardial wall.
2 more elements
Dependencies are inferred from the claim text.